An Act relative to pharmaceutical access, costs and transparency
Bill Information
Bill Information
- Sponsor:
- Senate Committee on Bills in the Third Reading
- Status:
- Referred to House Committee on Ways and Means
Bill History
Displaying 4 actions for Bill S.2520
| Date | Branch | Action |
|---|---|---|
| 11/15/2023 | Senate | Reported from the committee on Senate Bills in the Third Reading |
| 11/15/2023 | Senate | New draft of S2499 |
| 11/15/2023 | Senate | Passed to be engrossed -see Roll Call #99 (Yeas 39 to Nays 0) |
| 11/20/2023 | House | Read; and referred to the committee on House Ways and Means |
The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.